(2S,3S,4R,5R,6S)-2-[(1S,2S,4S,4'S,5'R,6R,7S,8R,9R,12R,13S,15S,16S)-16-[(2S,3S,4S,5R,6S)-5-[(2R,3S,4R,5S,6S)-3-[(2R,3S,4R,5S,6S)-3,5-dihydroxy-6-(hydroxymethyl)-4-[(2R,3S,4R,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-5-hydroxy-6-(hydroxymethyl)-4-[(2R,3S,4R,5S)-3,4,5-trihydroxyoxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-15-hydroxy-5',7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icos-18-ene-6,2'-oxane]-4'-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol

Details

Top
Internal ID 5bd68795-7050-4847-9a17-84a014642f24
Taxonomy Lipids and lipid-like molecules > Steroids and steroid derivatives > Steroidal glycosides > Steroidal saponins
IUPAC Name (2S,3S,4R,5R,6S)-2-[(1S,2S,4S,4'S,5'R,6R,7S,8R,9R,12R,13S,15S,16S)-16-[(2S,3S,4S,5R,6S)-5-[(2R,3S,4R,5S,6S)-3-[(2R,3S,4R,5S,6S)-3,5-dihydroxy-6-(hydroxymethyl)-4-[(2R,3S,4R,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-5-hydroxy-6-(hydroxymethyl)-4-[(2R,3S,4R,5S)-3,4,5-trihydroxyoxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-15-hydroxy-5',7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icos-18-ene-6,2'-oxane]-4'-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol
SMILES (Canonical) CC1COC2(CC1OC3C(C(C(C(O3)CO)O)O)O)C(C4C(O2)CC5C4(CCC6C5CC=C7C6(CC(C(C7)OC8C(C(C(C(O8)CO)OC9C(C(C(C(O9)CO)O)OC1C(C(C(CO1)O)O)O)OC1C(C(C(C(O1)CO)O)OC1C(C(C(C(O1)CO)O)O)O)O)O)O)O)C)C)C
SMILES (Isomeric) C[C@@H]1CO[C@@]2(C[C@@H]1O[C@@H]3[C@H]([C@@H]([C@H]([C@@H](O3)CO)O)O)O)[C@H]([C@H]4[C@@H](O2)C[C@@H]5[C@]4(CC[C@@H]6[C@H]5CC=C7[C@]6(C[C@@H]([C@H](C7)O[C@@H]8[C@H]([C@@H]([C@H]([C@@H](O8)CO)O[C@@H]9[C@H]([C@@H]([C@H]([C@@H](O9)CO)O)O[C@@H]1[C@H]([C@@H]([C@H](CO1)O)O)O)O[C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)CO)O)O[C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)CO)O)O)O)O)O)O)O)C)C)C
InChI InChI=1S/C62H100O34/c1-20-18-84-62(12-30(20)86-55-46(79)42(75)38(71)31(13-63)87-55)21(2)36-29(96-62)10-25-23-6-5-22-9-28(26(68)11-61(22,4)24(23)7-8-60(25,36)3)85-56-48(81)44(77)50(35(17-67)91-56)92-59-53(52(41(74)34(16-66)90-59)94-54-45(78)37(70)27(69)19-83-54)95-58-49(82)51(40(73)33(15-65)89-58)93-57-47(80)43(76)39(72)32(14-64)88-57/h5,20-21,23-59,63-82H,6-19H2,1-4H3/t20-,21+,23-,24-,25+,26+,27+,28+,29+,30+,31+,32+,33+,34+,35+,36+,37-,38+,39+,40+,41+,42-,43-,44+,45+,46+,47+,48+,49+,50+,51-,52-,53+,54-,55+,56+,57-,58-,59-,60-,61-,62-/m1/s1
InChI Key RYVMUASDIZQXAA-IWQVQEDWSA-N
Popularity 0 references in papers

Physical and Chemical Properties

Top
Molecular Formula C62H100O34
Molecular Weight 1389.40 g/mol
Exact Mass 1388.6096002 g/mol
Topological Polar Surface Area (TPSA) 534.00 Ų
XlogP -6.30
Atomic LogP (AlogP) -8.76
H-Bond Acceptor 34
H-Bond Donor 20
Rotatable Bonds 17

Synonyms

Top
There are no found synonyms.

2D Structure

Top
2D Structure of (2S,3S,4R,5R,6S)-2-[(1S,2S,4S,4'S,5'R,6R,7S,8R,9R,12R,13S,15S,16S)-16-[(2S,3S,4S,5R,6S)-5-[(2R,3S,4R,5S,6S)-3-[(2R,3S,4R,5S,6S)-3,5-dihydroxy-6-(hydroxymethyl)-4-[(2R,3S,4R,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-5-hydroxy-6-(hydroxymethyl)-4-[(2R,3S,4R,5S)-3,4,5-trihydroxyoxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-15-hydroxy-5',7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icos-18-ene-6,2'-oxane]-4'-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.7571 75.71%
Caco-2 - 0.8758 87.58%
Blood Brain Barrier - 0.6750 67.50%
Human oral bioavailability - 0.7857 78.57%
Subcellular localzation Mitochondria 0.7376 73.76%
OATP2B1 inhibitior - 1.0000 100.00%
OATP1B1 inhibitior + 0.8703 87.03%
OATP1B3 inhibitior + 0.8994 89.94%
MATE1 inhibitior - 0.9800 98.00%
OCT2 inhibitior - 0.5500 55.00%
BSEP inhibitior + 0.9076 90.76%
P-glycoprotein inhibitior + 0.7423 74.23%
P-glycoprotein substrate + 0.6485 64.85%
CYP3A4 substrate + 0.7586 75.86%
CYP2C9 substrate - 0.8054 80.54%
CYP2D6 substrate - 0.8216 82.16%
CYP3A4 inhibition - 0.9268 92.68%
CYP2C9 inhibition - 0.9182 91.82%
CYP2C19 inhibition - 0.9234 92.34%
CYP2D6 inhibition - 0.9343 93.43%
CYP1A2 inhibition - 0.9102 91.02%
CYP2C8 inhibition + 0.8015 80.15%
CYP inhibitory promiscuity - 0.9302 93.02%
UGT catelyzed - 0.5000 50.00%
Carcinogenicity (binary) - 0.9900 99.00%
Carcinogenicity (trinary) Non-required 0.5116 51.16%
Eye corrosion - 0.9898 98.98%
Eye irritation - 0.8999 89.99%
Skin irritation + 0.4929 49.29%
Skin corrosion - 0.9426 94.26%
Ames mutagenesis - 0.8500 85.00%
Human Ether-a-go-go-Related Gene inhibition + 0.8557 85.57%
Micronuclear - 0.8700 87.00%
Hepatotoxicity - 0.8000 80.00%
skin sensitisation - 0.9214 92.14%
Respiratory toxicity + 0.7667 76.67%
Reproductive toxicity + 0.9222 92.22%
Mitochondrial toxicity + 0.5375 53.75%
Nephrotoxicity - 0.9066 90.66%
Acute Oral Toxicity (c) I 0.5904 59.04%
Estrogen receptor binding + 0.8570 85.70%
Androgen receptor binding + 0.7524 75.24%
Thyroid receptor binding + 0.5880 58.80%
Glucocorticoid receptor binding + 0.7163 71.63%
Aromatase binding + 0.6762 67.62%
PPAR gamma + 0.8203 82.03%
Honey bee toxicity - 0.5624 56.24%
Biodegradation - 0.7000 70.00%
Crustacea aquatic toxicity - 0.5400 54.00%
Fish aquatic toxicity + 0.9176 91.76%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 98.76% 96.09%
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 98.29% 91.11%
CHEMBL226 P30542 Adenosine A1 receptor 97.01% 95.93%
CHEMBL218 P21554 Cannabinoid CB1 receptor 96.81% 96.61%
CHEMBL3137262 O60341 LSD1/CoREST complex 94.34% 97.09%
CHEMBL1994 P08235 Mineralocorticoid receptor 93.34% 100.00%
CHEMBL1907602 P06493 Cyclin-dependent kinase 1/cyclin B1 91.06% 91.24%
CHEMBL4203 Q9HAZ1 Dual specificity protein kinase CLK4 90.98% 94.45%
CHEMBL4187 Q99250 Sodium channel protein type II alpha subunit 90.01% 95.50%
CHEMBL1914 P06276 Butyrylcholinesterase 88.62% 95.00%
CHEMBL4681 P42330 Aldo-keto-reductase family 1 member C3 88.34% 89.05%
CHEMBL1907603 Q05586 Glutamate NMDA receptor; GRIN1/GRIN2B 88.08% 95.89%
CHEMBL5255 O00206 Toll-like receptor 4 87.23% 92.50%
CHEMBL253 P34972 Cannabinoid CB2 receptor 86.53% 97.25%
CHEMBL4303 P08238 Heat shock protein HSP 90-beta 86.21% 96.77%
CHEMBL1293249 Q13887 Kruppel-like factor 5 85.68% 86.33%
CHEMBL5608 Q16288 NT-3 growth factor receptor 85.48% 95.89%
CHEMBL3359 P21462 Formyl peptide receptor 1 84.36% 93.56%
CHEMBL2635 P51452 Dual specificity protein phosphatase 3 84.18% 94.00%
CHEMBL237 P41145 Kappa opioid receptor 82.76% 98.10%
CHEMBL1806 P11388 DNA topoisomerase II alpha 82.16% 89.00%
CHEMBL1821 P08173 Muscarinic acetylcholine receptor M4 81.60% 94.08%
CHEMBL5163 Q9NY46 Sodium channel protein type III alpha subunit 80.80% 96.90%
CHEMBL2581 P07339 Cathepsin D 80.70% 98.95%
CHEMBL3351 Q13085 Acetyl-CoA carboxylase 1 80.36% 93.04%
CHEMBL2955 O95136 Sphingosine 1-phosphate receptor Edg-5 80.08% 92.86%

Plants that contains it

Top
Below are displayed all the plants proven (via scientific papers) to contain this compound!
To see more specific details click the taxa you are interested in.
Cestrum nocturnum

Cross-Links

Top
PubChem 162890743
LOTUS LTS0013683
wikiData Q105248160